Skip Nav Destination
1-3 of 3
Keywords: cholesterol efflux capacityClose
Biosci Rep (2023) BSR20221519.
Published: 16 January 2023
...Yume Mutsuda; Tsunehiro Miyakoshi; Yuna Horiuchi; Takahiro Kameda; Minoru Tozuka; Ryunosuke Ohkawa During the past decade, evaluation of high-density lipoprotein (HDL) functionality has been well studied for predicting cardiovascular disease risk. Cholesterol efflux capacity (CEC) is the strongest...
Biosci Rep (2020) 40 (8): BSR20201495.
Published: 04 August 2020
...Yuna Horiuchi; Shao-Jui Lai; Takahiro Kameda; Minoru Tozuka; Ryunosuke Ohkawa Cholesterol efflux capacity (CEC) is an atheroprotective function of high-density lipoprotein (HDL). CEC is currently measured using artificially prepared foam cells composed of cultured macrophage and 3 H-cholesterol...
Yuna Horiuchi, Ryunosuke Ohkawa, Shao-Jui Lai, Shitsuko Shimano, Michio Hagihara, Shuji Tohda, Takahiro Kameda, Minoru Tozuka
Biosci Rep (2019) 39 (4): BSR20190213.
Published: 02 April 2019
...Yuna Horiuchi; Ryunosuke Ohkawa; Shao-Jui Lai; Shitsuko Shimano; Michio Hagihara; Shuji Tohda; Takahiro Kameda; Minoru Tozuka Cholesterol efflux capacity (CEC) in atherosclerotic lesions is the main anti-atherosclerotic function of high-density lipoprotein (HDL). In recent studies, apolipoprotein...